Vaccines for Immune-Mediated Diseases


Patients with safe interceded incendiary ailments (IMID, for instance, RA, IBD or skin problem, square measure at increased danger of contamination, partially in light-weight of the malady itself, but for the foremost half in light-weight of treatment with immune modulatory or immunological disorder medications. in spite of their raised hazard for immunisation preventable upset, the immunisation scope in IMID patients is shockingly low.


    Related Conference of Vaccines for Immune-Mediated Diseases

    April 18-19, 2022

    Global Summit on Vaccines and Immunology

    Madrid, Spain
    June 23-24, 2022

    35th World Congress on Vaccines and Immunization

    Bangkok, Thailand
    September 05-06, 2022

    42nd Global Summit and Expo on Vaccines & Immunology

    Paris, France
    September 15-16, 2022

    International Conference on Vaccine and Vaccine research

    Paris, France
    October 07-08, 2022

    34th International Conference on Vaccines and Immunization

    Zurich, Switzerland
    November 04-05, 2022

    34th Annual Congress on Vaccine and Clinical Trials

    Toronto, Canada

    Vaccines for Immune-Mediated Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in